Novartis has offloaded two mid-phase mTORC1 inhibitors to PureTech Health in return for an equity stake and a source of future milestones and royalties.

Former FDA chief Califf leads a PCORI-backed research foundation, ex-Shire exec Shepard jumped to Eisai's oncology business, and Forty Seven hired former…

Boston University scientists found that using drugs that block the protein TLR4 can help control Ebola infection.

University of Michigan researchers have identified a large molecule that selectively attacks prostate tumors without harming healthy cells.

Tessa Therapeutics has bought Euchloe Bio for its suite of checkpoint inhibitors.

BioLineRx has bought Agalimmune to expand its immuno-oncology pipeline. The takeover adds the synthetic alpha-gal immunotherapy AGI-134 to BioLineRx’s pipeline…

The FDA approved Medtronic’s latest iteration of its CoreValve Evolut TAVR for patients who are too frail for open-heart surgery.

Former FDA commissioner Robert Califf, who was not asked back into his role by President Donald Trump, has become the new chair of the newly formed People-…